MedDataToolInvokana is a medication used to help adults with type 2 diabetes manage their blood sugar levels, reduce the risk of serious heart problems, and lower the risk of kidney disease in those with kidney issues. It works by preventing the kidneys from reabsorbing sugar back into the blood, which helps the body get rid of excess sugar through urine. You take it as a pill, starting with a dose of 100 mg once daily before your first meal, which can be increased to a maximum of 300 mg if needed. It's important to know that Invokana is not recommended for people with severe kidney problems or those with type 1 diabetes. Additionally, if you are taking insulin or certain other diabetes medications, be aware that this can increase the risk of low blood sugar.
✦
Uses
- Type 2 diabetes mellitus.
- Cardiovascular disease.
- End-stage kidney disease.
- Diabetic nephropathy with albuminuria.
◷
Dosage
Start with 100 mg once daily before the first meal.
Can increase to 300 mg once daily if needed.
Assess kidney function before starting.
Adjust dose for kidney impairment as needed.
Always follow your doctor's specific instructions for your dose.
⚠
Side effects
Common
Increased urinationUrinary tract infectionsFemale genital infectionsLower limb amputationDiabetic ketoacidosis
🛑
Warnings
⚠ Important warnings
- Not for type 1 diabetes patients.
- Not for patients with severe kidney issues.
- Risk of dehydration and low blood pressure.
- Monitor for urinary tract infections.
- Increased risk of lower limb amputations.
⇄
Drug interactions
- Rifampinmay reduce INVOKANA effectivenessCaution
- Insulinincreased risk of low blood sugarMonitor
- Digoxinincreased digoxin exposureCaution
- Lithiummay lower lithium levelsCaution
Ask about this drug
Answers pulled from the FDA label only.
Medical Disclaimer: This content is provided for informational and educational purposes only and is not intended as medical advice. Always consult a qualified healthcare provider before taking any medication.
Data Source: Publicly available drug labeling information from the U.S. Food and Drug Administration (FDA).
Data Source: Publicly available drug labeling information from the U.S. Food and Drug Administration (FDA).